Global Asthma Therapeutics Market Size & Outlook
Global asthma therapeutics market, 2018-2030 (US$M)
Related Markets
Global asthma therapeutics market highlights
- The global asthma therapeutics market generated a revenue of USD 26,409.9 million in 2023 and is expected to reach USD 37,910.5 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 5.3% by 2030.
- In terms of segment, anti- inflammatories accounted for a revenue of USD 16,470.9 million in 2023.
- Combination therapy is the most lucrative drug class segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Norway is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 26,409.9 million |
| Market revenue in 2030 | USD 37,910.5 million |
| Growth rate | 5.3% (CAGR from 2023 to 2030) |
| Largest segment | Anti- inflammatories |
| Fastest growing segment | Combination therapy |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Anti- inflammatories, Bronchodilators, Combination therapy |
Other key industry trends
- In terms of revenue, the North America accounted for 50.2% of the global asthma therapeutics market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Norway is the fastest growing regional market and is projected to reach USD 97.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Asthma Therapeutics Market Scope
Asthma Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global asthma therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to asthma therapeutics market will help companies and investors design strategic landscapes.
Anti- inflammatories was the largest segment with a revenue share of 62.37% in 2023. Horizon Databook has segmented the Global asthma therapeutics market based on anti- inflammatories, bronchodilators, combination therapy covering the revenue growth of each sub-segment from 2018 to 2030.
The global increase in the incidence of asthma has significantly raised the demand for therapeutics. Government and nongovernment organizations emphasize the rapid growth in asthma patients, labeling it a severe public health concern. For instance, WHO reported in 2021 that 39.6% of adults with asthma experienced one or more attacks, a figure expected to rise and contribute to the global adoption of asthma therapeutics.
There is a rapid growth in the incidence of asthma in the Asia Pacific and Europe. A 2022 study in Public Health Challenges shows that an estimated 65% of asthma patients in the UK approximately 3.5 million people did not receive optimal asthma care. This underscores a potential surge in demand for asthma therapeutics, driving the market.
Reasons to subscribe to Global asthma therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global asthma therapeutics market databook
-
Our clientele includes a mix of asthma therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global asthma therapeutics market , including forecasts for subscribers. This global databook contains high-level insights into Global asthma therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global asthma therapeutics market size, by regions, 2018-2030 (US$M)
Top 10 countries: Asthma therapeutics market size, 2023 (US$M)
Global asthma therapeutics market share, by drug class, 2023 & 2030 (%, US$M)
Asthma therapeutics market: Opportunity assessment by country
Global asthma therapeutics market, by region, 2023 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
